Crossmark

ASO Visual Abstract: Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin

Crossref DOI link: https://doi.org/10.1245/s10434-025-17505-4

Published Online: 2025-05-30

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sugase, Takahito

Kanemura, Takashi

Matsuura, Norihiro

Takeoka, Tomohira

Ushimaru, Yuki

Masuike, Yasunori

Yanagimoto, Yoshitomo

Yamamoto, Kazuyoshi

Omori, Takeshi

Mori, Ryota

Kitakaze, Masatoshi

Kubo, Masahiko

Mukai, Yosuke

Komatsu, Hisateru

Sueda, Toshinori

Kagawa, Yoshinori

Wada, Hiroshi

Yasui, Masayoshi

Miyata, Hiroshi
License Information

Text and Data Mining valid from 2025-05-30

Version of Record valid from 2025-05-30
More Information

Article History

First Online: 30 May 2025

Disclosure

: The authors declare no conflicts of interest for this article.

Document is current

Any future updates will be listed below